Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit
Stephanie Goletz(University of Lübeck), Enno Schmidt(University Hospital Schleswig-Holstein), Manuela Pigors(University of Lübeck), Lars Komorowski(Mayo Clinic), Maike M. Holtsche(University of Lübeck), Swantje Mindorf(Mayo Clinic), Detlef Zillikens(University of Lübeck), Christian Probst(Mayo Clinic), Nina van Beek(University Hospital Schleswig-Holstein), Wolfgang Schlumberger(Euroimmun Medizinische Labordiagnostika (Germany)), Christiane Radzimski(Euroimmun Medizinische Labordiagnostika (Germany))
Cited by 12
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|586
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies
|Journal of Investigative Dermatology|1997|309